Botulinum toxin treatment of occupational and focal hand dystonia

Authors

  • Barbara Illowsky Karp MD

    Corresponding author
    1. National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA
    • Building 10, Room 5S-209, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892
    Search for more papers by this author

Abstract

Botulinum toxin is now the first-line therapy for writer's cramp and other occupational dystonias, with well-established efficacy and safety. Future studies will allow us to understand better the physiological effects of injection and to refine and enhance our treatment of focal hand dystonia. © 2004 Movement Disorder Society

Ancillary